Position in AZN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$385,307
New position
Shares Held
2,032
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
#949
of 1,459 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Vantus Wealth LLC holds $6,712,710 across 11 Drug Manufacturers - General names. AZN ranks #7 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
4,974 | $1,251,656 | |
| 2 | JNJ |
Johnson & Johnson
|
4,860 | $1,234,293 | |
| 3 | LLY |
ELI LILLY & Co
|
976 | $1,170,643 | |
| 4 | MRK |
Merck & Co., Inc.
|
5,250 | $674,625 | |
| 5 | PFE |
Pfizer Inc
|
22,727 | $547,265 | |
| 6 | AMGN |
Amgen Inc
|
1,262 | $456,995 | |
| 7 | AZN |
Astrazeneca PLC
This page
|
2,032 | $385,307 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,852 | $360,321 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $385,307 | 2,032 | Shares | Sole | 2026-08-07 | |
| No filing history on record for this holder in this stock. | ||||||